112 related articles for article (PubMed ID: 7524219)
1. Clinical evaluation of trough levels and area under the curve in cyclosporine- and FK 506-treated kidney transplant recipients.
Takahara S; Kokado Y; Kameoka H; Takano Y; Moutabarrik A; Jiang H; Ishibashi M; Okuyama A; Nishi Y; Chiba N
Transplant Proc; 1994 Oct; 26(5):2802-6. PubMed ID: 7524219
[No Abstract] [Full Text] [Related]
2. The area under the concentration-time curve versus trough and peak blood level monitoring in renal transplant recipients on cyclosporine.
Halim MA; Nampoory MR; Johny KV; Donia F; Hamid MH; Said T; Nair MP; Mansour M; Al-Muzairai I; Samhan M; Al-Mousawi M
Transplant Proc; 2005 Sep; 37(7):3019-21. PubMed ID: 16213291
[TBL] [Abstract][Full Text] [Related]
3. The superior immunosuppressant according to diagnosis: FK 506 or cyclosporine A.
Mueller AR; Platz KP; Blumhardt G; Bechstein WO; Steinmüller T; Christe W; Hopf U; Lobeck H; Neuhaus P
Transplant Proc; 1995 Feb; 27(1):1117-20. PubMed ID: 7533359
[No Abstract] [Full Text] [Related]
4. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
Shenoy S; Hardinger KL; Crippin J; Korenblat K; Lisker-Melman M; Lowell JA; Chapman W
Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391
[TBL] [Abstract][Full Text] [Related]
5. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center.
Kim HC; Hwang EA; Han SY; Park SB; Kim HT; Cho WH
Transplant Proc; 2004 Sep; 36(7):2082-3. PubMed ID: 15518753
[TBL] [Abstract][Full Text] [Related]
6. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
[TBL] [Abstract][Full Text] [Related]
7. Paired kidney analysis of tacrolimus and cyclosporine microemulsion-based therapy in Chinese cadaveric renal transplant recipients.
Cheung CY; Wong KM; Chan HW; Liu YL; Chan YH; Wong HS; Chak WL; Choi KS; Chau KF; Li CS
Transpl Int; 2006 Aug; 19(8):657-66. PubMed ID: 16827683
[TBL] [Abstract][Full Text] [Related]
8. Increased rejection after liver transplantation in FK 506-treated patients is associated with viral hepatitis C disease.
Mueller AR; Platz KP; Bechstein WO; Blumhardt G; Lobeck H; Hop U; Neuhaus P
Transplant Proc; 1994 Dec; 26(6):3637-9. PubMed ID: 7527984
[No Abstract] [Full Text] [Related]
9. Monitoring of FK 506 blood levels in kidney transplant recipients.
Takahara S; Kokado Y; Kameoka H; Takano Y; Jiang H; Moutabarrik A; Ishibashi M; Okuyama A; Sonoda T
Transplant Proc; 1994 Aug; 26(4):2106-8. PubMed ID: 7520623
[No Abstract] [Full Text] [Related]
10. Treatment of acute renal transplant rejection with FK 506 in patients on cyclosporine after failure of standard antirejection therapy.
Scott-Douglas N; Zimmerman D; Klassen J
Transplant Proc; 1996 Dec; 28(6):3165. PubMed ID: 8962226
[No Abstract] [Full Text] [Related]
11. Evidence of different pharmacokinetics between cyclosporine and tacrolimus in renal transplant recipients: why cyclosporine is monitored by C2 level and tacrolimus by trough level.
Takeuchi H; Matsuno N; Hirano T; Toraishi T; Konno O; Nakamura Y; Iwamoto H; Hama K; Unezaki S; Nagao T
Transplant Proc; 2008 Sep; 40(7):2240-2. PubMed ID: 18790203
[TBL] [Abstract][Full Text] [Related]
12. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO
Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
[No Abstract] [Full Text] [Related]
13. FK 506 induction and rescue therapy in pancreas transplant recipients.
Stratta RJ; Taylor RJ; Castaldo P; Sindhi R; Sudan D; Weide LG; Frisbie K; Cushing KA; Jerius J; Radio SJ
Transplant Proc; 1996 Apr; 28(2):991-2. PubMed ID: 8623492
[No Abstract] [Full Text] [Related]
14. Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation.
Yu L; Wang Y; Fu SJ; Cheng XJ
Transplant Proc; 2000 Nov; 32(7):1709-10. PubMed ID: 11119902
[No Abstract] [Full Text] [Related]
15. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
[No Abstract] [Full Text] [Related]
16. Neurotoxicity of FK 506 in liver transplant recipients.
Frank B; Perdrizet GA; White HM; Marsh JW; Lemann W; Woodle ES
Transplant Proc; 1993 Apr; 25(2):1887-8. PubMed ID: 7682355
[No Abstract] [Full Text] [Related]
17. New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients.
Scantlebury V; Shapiro R; Fung J; Tzakis A; McCauley J; Jordan M; Jensen C; Hakala T; Simmons R; Starzl TE
Transplant Proc; 1991 Dec; 23(6):3169-70. PubMed ID: 1721395
[No Abstract] [Full Text] [Related]
18. Japanese multicenter studies of FK 506 in renal transplantation. Japanese FK 506 Study Group.
Ochiai T; Ishibashi M; Fukao K; Takahashi K; Endo T; Yokoyama I; Uchida K; Ohshima S; Takahara S; Morozumi K
Transplant Proc; 1995 Feb; 27(1):50-3. PubMed ID: 7533419
[No Abstract] [Full Text] [Related]
19. Chronic rejection in 500 kidney transplant patients treated with cyclosporine: incidence and risk factors.
Pallardó LM; Sánchez J; Puig N; Sánchez P; Beneyto I; Crespo J; Ros F; Rochera A
Transplant Proc; 1995 Aug; 27(4):2215-6. PubMed ID: 7652778
[No Abstract] [Full Text] [Related]
20. Evaluation of appropriate blood level in continuous intravenous infusion from trough concentrations after oral administration based on area under trough level in tacrolimus and cyclosporine therapy.
Nakamura Y; Takeuchi H; Okuyama K; Akashi T; Jojima Y; Konno O; Akashi I; Hama K; Iwahori T; Ashizawa T; Hirano T; Oka K; Matsuno N; Nagao T
Transplant Proc; 2005 May; 37(4):1725-7. PubMed ID: 15919445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
